5-Amino-1MQ (10 mg Vial) Questions Answered
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its metabolic effects in preclinical models [1] [2] .
True NorthHealth Labs
Build
TNHL peptide answers
Browse answer-first protocol pages built from the TNHL protocol library. Educational reference only; use this to organize questions and review details with a qualified professional.
5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its metabolic effects in preclinical models [1] [2] .
5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels [1] [2] .
Adamax is an adamantane‑modified analog of Semax (N‑acetyl Semax Amidate), a heptapeptide derivative of ACTH (4–10) studied for nootropic and neuroprotective properties [1] [2] .
AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK) [1] , earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance impr...
AOD-9604 (human growth hormone fragment 177–191) is a short peptide investigated for its effects on fat metabolism.
AOD-9604 dosage protocol is designed to support targeted fat loss and metabolic improvements through daily subcutaneous injections.
The AOD-9604 6mg + CJC-1295 3mg + Ipamorelin 3mg (12mg Blend Vial) dosage protocol is designed for research purposes to explore potential metabolic, regenerative, and fat oxidation effects via daily subcutaneous injections.
Ara-290 (also known as cibinetide) is a non-erythropoietic peptide derived from erythropoietin that engages the Innate Repair Receptor (IRR).
Typical daily dose ranges from 300–500 mcg Often administered 1–2 times per day for 4–8 weeks Higher dosing protocols (500–750 mcg, 2–3x daily) are considered more “advanced” Reconstitute to achieve a practical injection volume (avoid extremely low syringe...
BPC-157 (pentadecapeptide) is widely studied preclinically for cytoprotection, angiogenesis, and tissue repair mechanisms.
Reconstitute: Add 3.0 mL bacteriostatic water → 3.33 mg/mL total concentration (1.67 mg/mL of each peptide).
BPC157 + TB500 (20mg) dosage protocol is designed to support tissue repair, enhance recovery, and promote regenerative benefits through daily or phased subcutaneous injections Often used for injury recovery, tendon/ligament health, and general tissue suppor...
Slow, steady dose escalation helps minimize GI side effects Once-weekly injection schedule for user convenience May be reconstituted to ~3.33 mg/mL or 5 mg/mL for practical dosing Store lyophilized vials in the freezer; reconstituted in the refrigerator Use...
Cagrilintide 5mg dosage protocol is investigated primarily for weight management and metabolic control via once-weekly subcutaneous injections.
Cagrilintide + Semaglutide (10mg blend) dosage protocol offers a once-weekly subcutaneous injection approach aimed at supporting weight management and glycemic control.
Cardiogen is a synthetic cardiovascular bioregulator tetrapeptide (AEDR: Ala‑Glu‑Asp‑Arg) studied for its cellular repair and cardioprotective properties [1] [2] .
Cartalax (Ala‑Glu‑Asp; “AED”) is described in the scholarly literature as an ultrashort, cartilage‑associated peptide motif that can influence fibroblast activity and extracellular‑matrix regulation in vitro.
Cerebrolysin is a porcine brain‑derived peptide preparation containing low‑molecular‑weight neuropeptides and free amino acids that crosses the blood–brain barrier to support neuronal survival [1] .
Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration. Typical daily range: 250–4,000 mcg once daily (gradual titration over 8–16 weeks).
CJC-1295 is a long-acting GHRH analog that can elevate GH levels 2–10× baseline for approximately 6 days and increase IGF-1 by 1.5–3× for 9–11 days [1] .
CJC-1295 DAC: 1–2 mg weekly (1× or split into 2× injections) Ipamorelin: 200–300 μg/day (usually 1×–2× daily) Reconstitute CJC-1295 DAC in 1 mL bacteriostatic water (2 mg/mL) Reconstitute Ipamorelin in 2–3 mL bacteriostatic water (1.67–2.5 mg/mL) Store reco...
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
CJC-1295 DAC (5 mg Vial) & Ipamorelin (5 mg Vial) dosage protocol combines two research peptides frequently studied together for their synergistic effects on growth hormone (GH) release.
CJC-1295 DAC is a long-acting synthetic analog of growth hormone-releasing hormone (GHRH).
CJC-1295 NO DAC (also known as Modified GRF 1–29 or Mod GRF) is a synthetic 29‑amino‑acid peptide analog of growth hormone–releasing hormone (GHRH) with a plasma half‑life of approximately 30 minutes [1] .
CJC1295 NO DAC + Ipamorelin 10mg dosage protocol supports enhanced growth hormone release and recovery through daily subcutaneous injections.
Cortagen is an ultrashort tetrapeptide Ala–Glu–Asp–Pro (AEDP) , synthesized as a defined fragment based on the bovine brain-cortex extract Cortexin.
Reconstitute: Add 3.0 mL bacteriostatic water → 6.67 mg/mL concentration. Typical daily range: 1000–2000 mcg once daily (gradual titration to 2000 mcg).
Most‑studied human dose: ~25 nmol/kg (≈21 µg/kg) per injection Frequency: 1× daily; courses of 1–4 consecutive days were commonly explored Reconstitution: Use the full 3 mL (max vial capacity) → ~3.33 mg/mL for easy unit counting Units math: At 3 mL, each 1...
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (9 amino acids) first isolated from rabbit brain tissue and studied for its effects on sleep architecture and stress modulation[1][2].
Epitalon (also known as Epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed from the naturally occurring pineal peptide epithalamin [1] .
FOXO4-DRI (also known as Proxofim) is a synthetic D-retro-inverso peptide designed to selectively induce apoptosis in senescent cells by disrupting the FOXO4–p53 protein interaction [1] [2] .
GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration [1] [2] .
GHK-Cu (glycyl-L-histidyl-L-lysine:copper complex) is a naturally occurring copper peptide with documented roles in wound healing, tissue remodeling, and skin regeneration [1] [2] .
GHRP-2 (pralmorelin) is a synthetic hexapeptide that potently stimulates growth hormone release by activating ghrelin receptors in the pituitary and hypothalamus [1] [2] .
GHRP-2 (Growth Hormone-Releasing Peptide-2) is a synthetic hexapeptide that stimulates potent, dose-dependent growth hormone release by activating ghrelin receptors [1] .
GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] .
GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] .
GHRP-6 (Growth Hormone-Releasing Peptide 6) is a synthetic hexapeptide that functions as a potent growth hormone secretagogue by binding to the ghrelin receptor (GHS-R1a) [1] [2] .
GLOW is a research peptide blend combining GHK-Cu , TB-500 (Thymosin Beta-4 fragment), and BPC-157 in one 70 mg vial.
Glutathione (GSH) is a tripeptide composed of glutamine, cysteine, and glycine that serves as the body’s master antioxidant [1] .
Gonadorelin is a synthetic gonadotropin-releasing hormone (GnRH) that stimulates pituitary release of LH and FSH [1] .
Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that mimics luteinizing hormone (LH) by binding to LH receptors in the gonads [1] .
HGH 191AA is recombinant human growth hormone (somatropin) identical to endogenous GH, studied extensively for its effects on body composition, metabolism, and tissue repair [1] [7] .
Human Menopausal Gonadotropin (HMG) is a purified gonadotropin preparation containing equal amounts of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity [1] [2] .
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified analog of human IGF-1 with significantly extended half-life, studied for its anabolic and metabolic effects [1] .
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor [1] [2] .
Ipamorelin is a synthetic pentapeptide that acts as a selective growth hormone secretagogue by mimicking ghrelin at the GH secretagogue receptor [1] [2] .
Ipamorelin 5mg + Tesamorelin 5mg (10mg Blend) dosage protocol combines two growth-hormone–oriented peptides for research into lean muscle support, fat reduction, and potential metabolic improvements.
Kisspeptin (also known as metastin) is a naturally occurring neuroendocrine peptide that plays a pivotal role in human reproduction by stimulating gonadotropin-releasing hormone (GnRH) secretion [1] .
KLOW is a four-peptide blend (GHK-Cu, BPC-157, KPV, TB-500) formulated for advanced tissue repair and inflammation reduction.
KPV (Lysine–Proline–Valine) is a C‑terminal tripeptide fragment of α‑melanocyte‑stimulating hormone (α‑MSH) studied for its potent anti‑inflammatory properties without melanotropic side effects[1][2].
L-Carnitine is an amino acid derivative essential for fatty acid transport into mitochondria, where it facilitates β-oxidation and energy production [1] .
Livagen is a synthetic tetrapeptide ( Lys‑Glu‑Asp‑Ala ) examined for chromatin remodeling and gene‑expression effects in aging cells.
LL‑37 (human cathelicidin) is a multifunctional host‑defense peptide with broad antimicrobial, immunomodulatory, and pro‑healing properties [1] [2] [3] .
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.
Mazdutide (IBI362) is a long‑acting dual GLP‑1/glucagon receptor agonist developed for chronic weight management and type 2 diabetes.
Melanotan II: 0.25–0.5 mg per injection, 2×/week for 4 weeks PT-141: 1.75 mg per injection, as-needed (max 1/24 h, ≤ 8/mo) Typical Melanotan II cycle: 4 weeks; PT-141 is on-demand Reconstitute each vial with bacteriostatic water (max 3 mL) Store the reconst...
Melanotan II is a synthetic analog of α-melanocyte-stimulating hormone studied for its ability to increase skin pigmentation and noted for inducing erectile activity as a side effect [1] .
Mechano Growth Factor (MGF) is the human IGF‑1Ec splice variant produced locally in response to mechanical loading and tissue injury; it has been explored predominantly in vitro and in animal models for roles in repair and cell activation.
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation [1] [2] .
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation [1] [2] .
MOTS-c is a 16–amino-acid mitochondrial-derived peptide (MDP) that acts as a metabolic regulator, primarily through AMPK activation [1] [2] .
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function [1] .
NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function [1] .
Ovagen is described in the scientific literature as an ultra‑short regulatory peptide; ultra‑short peptides can modulate gene expression and cellular programs, including in epithelial and parenchymal tissues [1] [2] .
Oxytocin is a peptide hormone (nonapeptide) known for its role in childbirth and lactation, and it also influences social bonding and behavior [1] .
Oxytocin is a peptide hormone (nonapeptide) known for its role in childbirth and lactation, and it also influences social bonding and behavior [1] .
PE-22-28 is a synthetic heptapeptide (sequence: GVSWGLR) derived from the sortilin propeptide, engineered as a potent and selective antagonist of TREK-1 potassium channels [4] .
DP Protocol Pal Dosing Info Guide FAQs Peptide Storage Supplies Needed Syringes Reconstitution Subcutaneous Injection Intramuscular Injection 📘 Complete Guide Prep & Injection Guide Everything you need to know about peptide storage, reconstitution, and adm...
Pinealon (also known as EDR ; sequence Glu‑Asp‑Arg ) is an ultrashort tripeptide investigated for neuroprotective and epigenetic regulatory effects, with most peer‑reviewed data from in vitro and animal studies and limited human observations [1] [2] [3] [4]...
PNC-27 is a synthetic 32‑amino‑acid peptide containing an HDM‑2‑binding domain linked to a membrane‑penetrating sequence, studied preclinically for its selective cytotoxicity toward cancer cells expressing abnormal p53/HDM‑2 complexes [1] [2] .
Prostamax is a synthetic bioregulator tetrapeptide (Lys‑Glu‑Asp‑Pro) described as prostate‑tissue–specific in preclinical literature[1].
PT‑141 (bremelanotide) is a melanocortin receptor agonist that acts centrally—predominantly via MC4R—to influence sexual desire pathways [7] [8] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Retatrutide is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors [1] , studied for substantial weight loss and metabolic improvement in obesity and type 2 diabetes [2] [3] .
Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials [1] [2] .
Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials [1] [2] .
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist with a prolonged half-life of approximately 7 days [1] , approved for chronic weight management and glycemic control.
Semax is a synthetic heptapeptide analog of ACTH(4–10) developed in Russia and studied primarily for cognitive enhancement and neuroprotection [1] [2] .
Semax 5mg dosage protocol is commonly used to support cognitive function, neuroprotection, and potential stroke recovery through subcutaneous injections.
Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] .
Sermorelin is a synthetic growth hormone–releasing hormone (GHRH) analog that stimulates endogenous pituitary GH secretion [1] .
PRECLINICAL RESEARCH COMPOUND: SLU-PP-332 is a synthetic pan-agonist of estrogen-related receptors (ERRα/β/γ) studied exclusively in murine models for its ability to activate an aerobic-exercise gene program, enhance mitochondrial function, and improve endu...
SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide originally developed as a cosmeceutical ingredient for anti-wrinkle effects [1] [2] .
SS‑31 (elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane [1] , stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synt...
SS‑31 (elamipretide) is a mitochondria‑targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane [1] , stabilizing electron transport chain complexes and reducing reactive oxygen species production while enhancing ATP synt...
Survodutide (BI 456906) is a dual glucagon/GLP‑1 receptor agonist investigated for obesity and related metabolic conditions.
TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] .
TB‑500 is a synthetic peptide fragment corresponding to the active region of thymosin beta‑4 (Tβ4), a naturally occurring 43‑amino‑acid protein involved in tissue repair and regeneration [1] [2] .
TB-500 & BPC-157 dosage protocol combines two research peptides often used together for synergistic tissue repair and recovery.
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH) [1] .
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH) [1] .
Tesamorelin is a synthetic 44-amino-acid peptide analog of Growth Hormone-Releasing Hormone (GHRH) [1] .
Testagen is a synthetic tetrapeptide with the sequence Lys‑Glu‑Asp‑Gly (KEDG), an anterior pituitary‑derived bioregulator studied for its role in modulating endocrine function, particularly the pituitary–gonadal axis [1] [2] .
Thymosin Alpha-1 (Tα1) is a 28–amino acid peptide originally isolated from the thymus gland, recognized for its broad immunomodulatory properties [1] .
Thymosin Alpha-1 (Tα1) is a 28–amino acid peptide originally isolated from the thymus gland, recognized for its broad immunomodulatory properties [1] .
Tirzepatide is a 39–amino acid dual incretin receptor agonist that activates both GLP‑1 and GIP receptors, enhancing glucose‑dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2] .
Tirzepatide is a 39–amino acid dual incretin receptor agonist that activates both GLP‑1 and GIP receptors, enhancing glucose‑dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2] .
Tirzepatide is a 39–amino acid dual incretin receptor agonist that activates both GLP‑1 and GIP receptors, enhancing glucose‑dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2] .
Tirzepatide is a 39–amino acid dual incretin receptor agonist that activates both GLP‑1 and GIP receptors, enhancing glucose‑dependent insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite [1] [2] .
Tri-Heal dosage protocol supports accelerated tissue repair and inflammation control through once-daily subcutaneous (or intramuscular) micro-injections.
Vesugen (Lys-Glu-Asp, also known as KED) is a tripeptide bioregulator synthesized at the Saint Petersburg Institute of Bioregulation and Gerontology [1] .
Vilon (Lys‑Glu) is a synthetic immunoregulatory dipeptide consisting of lysine and glutamic acid residues [1] .